Abstract: A pelletizing apparatus includes a filter device connected with a melt feed, a granulator downstream of the filter device, particularly an underwater granulator, a water treatment device, and a control means for controlling the filter device, underwater granulator, and water treatment device and adapted to provide at least one control parameter.

Abstract: A method for preventing and/or treating a tumor, the method comprising: intravenously administering an antisense oligonucleotide in an amount of between about 400 to about 800 mg/m2/treatment cycle, the antisense oligonucleotide comprises 8 to 30 nucleotide building blocks, which hybridizes with mRNA of TGF-beta-2, -1 and/or -3 for the preparation of a pharmaceutical composition.

Abstract: A printing machine or press including at least one printing unit having at least one frame wall. The at least one frame wall defines a machine space of the machine unit. The at least one frame wall has a thickness and includes a narrow side. At least one passage is formed in the frame wall and is at least partially open. The at least one passage is formed on at least one surface of the frame wall and with its surface opening disposed on the narrow side of the frame wall and which extends along the surface of the frame wall. At least one of a power line and a data line can be disposed in the passage.

Abstract: A printing machine or press including at least one printing unit having at least one frame wall. The at least one frame wall defines a machine space of the machine unit. The at least one frame wall has a thickness and includes a narrow side. At least one passage is formed in the frame wall and is at least partially open. The at least one passage is formed on at least one surface of the frame wall and with its surface opening disposed on the narrow side of the frame wall and which extends along the surface of the frame wall. At least one of a power line and a data line can be disposed in the passage.

Abstract: A method for preventing and/or treating a tumor, the method comprising: intravenously administering an antisense oligonucleotide in an amount of between about 400 to about 800 mg/m2/treatment cycle, the antisense oligonucleotide comprises 8 to 30 nucleotide building blocks, which hybridizes with mRNA of TGF-beta-2, -1 and/or -3 for the preparation of a pharmaceutical composition.

Abstract: A printing unit consists of at least two printing groups, which are placed vertically above each other, in a printing machine. Each of the printing groups includes a printing cylinder, an inking unit with at least one inking roller, a dampening unit with several dampening rollers arranged in a line, and a transfer cylinder that cooperates with the printing cylinder. The inking cylinder and the dampening roller, in an operational state in which they are adjacent the printing cylinder, form an obtuse opening angle with the printing cylinder. The rollers of the dampening unit are arranged with at least the first and last rollers in the roller train arranged inside an acute angle depending from the transfer cylinder. A horizontal line extending from the transfer cylinder defines an opening angle of less than 45° with the rollers of the dampening unit. A printing forme is fed to the printing cylinder through an obtuse angle between the dampening roller and the inking roller.